Brainstorm to Meet FDA on Parkinson’s Trials

Biopharmaceutical company BrainStorm Cell Therapeutics Ltd. has arranged a first meeting with the US Food and Drug Administration (FDA) to coordinate clinical trials for its flagship product for the treatment of Parkinson’s disease.
Globes